• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Large, crystalline lipid scaffolds bring new possibilities to protein,…

Bioengineer.org by Bioengineer.org
January 24, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Photo by L. Brian Stauffer

CHAMPAIGN, Ill. — Proteins and drugs are often attached to lipids to promote crystallization or ensure delivery to targeted tissues within the body, but only the smallest proteins and molecules fit within these fat structures. A new study reveals a lipid structure that can support much larger proteins and molecules than before, potentially increasing the variety of drugs that can be attached to these fat molecules.

The new findings are published in the Proceedings of the National Academy of Sciences.

Lipids are soft, gel-like materials that can organize themselves into materials having tiny pores that proteins and drugs can squeeze into for research and medical purposes. Although lipids make an excellent substrate for drug delivery, their small pores limit the variety of medicines that can hitch a ride, leaving behind the larger molecule drugs like insulin, said professor of materials science and engineering and study leader Cecilia Leal .

Lipids also act as scaffolds to prop up proteins for atomic structure analysis. Normally, proteins are too floppy to stand up to the types of X-ray analysis used to observe them, but lipids are just crystalline enough to hold them up for researchers to see inside of them. However, this only works for small-protein molecules.

"We found a way to crystallize a 3-D lipid structure with pore spaces that are five times the size of a regular lipid," Leal said. "Now we are able, in principle, to crystallize much bigger proteins as well as encapsulate much larger drug molecules than ever before."

Much of the significance of this research is a result of the new method the group used to prepare the lipid scaffolds.

"The materials are old; there is nothing new there," Leal said. "What we did differently was to find a new way to prepare the lipid cocktail to produce this unique material." In fact, Leal's group discovered this new preparation technique by accident.

"One of my students, a co-author of this study, had rushed the preparation process and later realized his mistake when he went to examine the lipid pore sizes in the material he had just produced," Leal said. "The pores were much larger than they should have been. We did not think that the large pores would remain stable, but they did, and the process is fully reproducible. Furthermore, the large porous lipid structure developed as a crystal, which is unusual for these soft materials. "

The study's findings are interesting from a scientific viewpoint, even paradigm-shifting, Leal said, because researchers do not associate lipid membranes with crystallinity, which is commonly found in hard materials. The group hopes that this will lead more scientists to look at these materials in a new way.

"However, it is the application of material to the study of proteins and drug delivery that will have the most impact," Leal said.

The National Institutes of Health and the Office of Naval Research supported this research.

###

Editor's notes:

To reach Cecilia Leal, call 217-300-1955; [email protected]

The paper "Super-swelled lyotropic single crystals" is available online and from the U. of I. News Bureau.

Media Contact

Lois E Yoksoulian
[email protected]
217-244-2788
@NewsAtIllinois

http://www.illinois.edu

Original Source

https://news.illinois.edu/blog/view/6367/562075 http://dx.doi.org/10.1073/pnas.1710774114

Share12Tweet8Share2ShareShareShare2

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.